About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: March 2009
The Virtual Clinic Experience – A Study in the UK is Just Another Reason for Everyone to Catch Up to Web 2.0
A paper out of the UK entitled "A Virtual Clinic for Diabetes Self-Management: A Study" was published in the current issue of the Journal of Medical Internet Research. The study, conducted by the Warwick Medical School, is not huge in … Continue reading
Posted in New and Social Media
Comments Off on The Virtual Clinic Experience – A Study in the UK is Just Another Reason for Everyone to Catch Up to Web 2.0
This is Your State – This is Your State on Drugs – an Ongoing Series
One of the considerable elements re-shaping the marketing of pharmaceuticals in the United States has been the outlooks and activities and probable future legislation under advisement by members of Congress. While the various actions at the federal level have dominated … Continue reading
Posted in Proposed Legislation
Comments Off on This is Your State – This is Your State on Drugs – an Ongoing Series
Weekly Roundup – 3/27/09
March madness is almost over, but my own seems to continue. What's that about? And I don't think the groundhog was right this year, Spring seems to be here in full force, at least by the looks of all the … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup – 3/27/09
How Risk Averse Have We Become?
Something I've written about before is the swing of the pendulum from the 1990s to the 2000s in terms of public priorities for the FDA. What is the balancing act between risk and benefit when it comes to both … Continue reading
Posted in Drug Safety, FDA Policy, Food
2 Comments
FDA Commissioner Appointed – Check. Deputy Appointed – Check. Now What?
Well the long era of suspense is over given the choices by the Obama Administration for the FDA and for HHS – in fact, the appointment game is winding down across the board, and federal agencies are getting down to … Continue reading
Posted in Current Affairs, FDA Policy
4 Comments